Contact Us
Biodefense Global Market Report 2025
Global Biodefense Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Biodefense Global Market Report 2025

By Type (Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types), By Biothreat Detection Device (Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices), By Application (Hospitals And Clinics, Ambulatory Care Centers, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Biodefense Market Overview

• Biodefense market size has reached to $18.55 billion in 2024

• Expected to grow to $28.1 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Impact Of Emerging Infectious Diseases Enhanced Biodefense Market

• Market Trend: Rapid Advancements In Biodefense Technologies And Products

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biodefense Market?

Biodefense refers to the measures and strategies implemented to protect against biological threats, including the deliberate release of pathogens or biotoxins. This involves the development of detection systems, vaccines, treatments, and emergency response plans to mitigate the impact of biological attacks on public health and safety. Biodefense also includes research and policy efforts to prevent the misuse of biological agents.

The main types of biodefense are anthrax, smallpox, botulism, radiation or nuclear, and others. Anthrax refers to a serious infectious disease caused by the bacterium Bacillus anthracis, affecting both humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Biothreat detection devices, including samplers, detectors or triggering devices, identifiers, Assays, and others, are used in applications such as hospitals and clinics, ambulatory care centers, and others.

Biodefense Market Size and growth rate 2025 to 2029: Graph

What Is The Biodefense Market Size 2025 And Growth Rate?

The biodefense market size has grown strongly in recent years. It will grow from $18.55 billion in 2024 to $20.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism.

What Is The Biodefense Market Growth Forecast?

The biodefense market size is expected to see strong growth in the next few years. It will grow to $28.1 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. national security by driving up the cost of anthrax vaccines and portable biocontainment units sourced from France and South Africa, exacerbating bioterrorism preparedness costs and limiting emergency stockpiles. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Biodefense Market Segmented?

1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types

2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices

3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications

Subsegments:

1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics

2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox

3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors

4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures

5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents

What Is Driving The Biodefense Market? Impact Of Emerging Infectious Diseases Enhanced Biodefense Market

The recurring threat of emerging infectious diseases is expected to propel the growth of the biodefense market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The reoccurrence of the threat of emerging infectious diseases highlights the growing challenges posed by pathogens, rapid response, global coordination, and preparedness in biodefense. Biodefense plays a crucial role in infectious disease management by enhancing preparedness, early detection, and rapid response to biological threats, thereby minimizing the impact of outbreaks on public health. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, IT is estimated that globally, there will be around 10.6 million cases of tuberculosis (TB) in 2022, impacting approximately 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the reoccurring threat of infectious diseases is driving the growth of the biodefense industry.

Who Are The Major Players In The Global Biodefense Market?

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

What Are The Key Trends Of The Global Biodefense Market? Rapid Advancements In Biodefense Technologies And Products

Major companies operating in the biodefense market are focused on developing innovative solutions, such as nasal COVID-19 vaccines, to enhance global preparedness against biological threats. Nasal vaccines enhance biodefense by offering easier administration, potential for mucosal immunity, reducing reliance on needles, enhancing accessibility, and potentially improving immune response. For instance, in January 2023, Bharat Biotech International Limited, an India-based biotechnology company, launched the iNCOVACC Nasal COVID-19 vaccine, utilizing a recombinant replication-deficient adenovirus vector and featuring a pre-fusion stabilized spike protein. After undergoing successful phase I, II, and III clinical trials, this vaccine is designed for intranasal delivery via nasal drops. It is administered as a nasal drop, with a total of 8 drops (0.5 mL per dose), 4 drops into each nostril, as a 2-dose series given 4 weeks apart.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Biodefense Market? Emergent BioSolutions Inc. Acquires Rights For TEMBEXA To Enhance Smallpox Treatment Portfolio

In September 2022, Emergent BioSolutions Inc., a US-based biotechnology company, acquired worldwide rights for the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. Emergent BioSolutions' acquisition of exclusive worldwide rights to TEMBEXA demonstrates their commitment to advancing public health initiatives and addressing global health threats. This development could potentially enhance preparedness and response capabilities against smallpox outbreaks. Chimerix Inc. is a US-based biotechnology research company that provides biodefense solutions.

What Is The Regional Outlook For The Global Biodefense Market?

North America was the largest region in the biodefense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biodefense Market?

The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Biodefense Industry?

The biodefense market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Biodefense Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $20.23 billion
Revenue Forecast In 2034 $28.1 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Anthrax, Smallpox, Botulism, Radiation Or Nuclear, Other Types
2) By Biothreat Detection Device: Samplers, Detectors Or Triggering Devices, Identifiers, Assays, Other Biothreat Detection Devices
3) By Application: Hospitals And Clinics, Ambulatory Care Centers, Other Applications Subsegments: 1) By Anthrax: Bacillus Anthracis Vaccine, Anthrax Therapeutics
2) By Smallpox: Smallpox Vaccine, Antiviral Drugs For Smallpox
3) By Botulism: Botulism Antitoxin, Botulism Vaccine, Botulinum Neurotoxin Inhibitors
4) By Radiation Or Nuclear: Radiation Protection Drugs, Medical Countermeasures
5) By Other Types: Ricin, Plague, Tularemia, Viral Hemorrhagic Fevers, Other Biotoxins Or Biothreat Agents
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Biodefense Market Characteristics

3. Biodefense Market Trends And Strategies

4. Biodefense Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Biodefense Growth Analysis And Strategic Analysis Framework

5.1. Global Biodefense PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Biodefense Market Growth Rate Analysis

5.4. Global Biodefense Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Biodefense Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Biodefense Total Addressable Market (TAM)

6. Biodefense Market Segmentation

6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anthrax

Smallpox

Botulism

Radiation Or Nuclear

Other Types

6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Samplers

Detectors Or Triggering Devices

Identifiers

Assays

Other Biothreat Detection Devices

6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Ambulatory Care Centres

Other Applications

6.4. Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bacillus Anthracis Vaccine

Anthrax Therapeutics

6.5. Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Smallpox Vaccine

Antiviral Drugs For Smallpox

6.6. Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Botulism Antitoxin

Botulism Vaccine

Botulinum Neurotoxin Inhibitors

6.7. Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radiation Protection Drugs

Medical Countermeasures

6.8. Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ricin

Plague

Tularemia

Viral Hemorrhagic Fevers

Other Biotoxins Or Biothreat Agents

7. Biodefense Market Regional And Country Analysis

7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biodefense Market

8.1. Asia-Pacific Biodefense Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biodefense Market

9.1. China Biodefense Market Overview

9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biodefense Market

10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biodefense Market

11.1. Japan Biodefense Market Overview

11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biodefense Market

12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biodefense Market

13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biodefense Market

14.1. South Korea Biodefense Market Overview

14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biodefense Market

15.1. Western Europe Biodefense Market Overview

15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biodefense Market

16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biodefense Market

17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biodefense Market

18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biodefense Market

19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biodefense Market

20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biodefense Market

21.1. Eastern Europe Biodefense Market Overview

21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biodefense Market

22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biodefense Market

23.1. North America Biodefense Market Overview

23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biodefense Market

24.1. USA Biodefense Market Overview

24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biodefense Market

25.1. Canada Biodefense Market Overview

25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biodefense Market

26.1. South America Biodefense Market Overview

26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biodefense Market

27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biodefense Market

28.1. Middle East Biodefense Market Overview

28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biodefense Market

29.1. Africa Biodefense Market Overview

29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biodefense Market Competitive Landscape And Company Profiles

30.1. Biodefense Market Competitive Landscape

30.2. Biodefense Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Biodefense Market Other Major And Innovative Companies

31.1. AstraZeneca Plc

31.2. GSK plc

31.3. Gilead Sciences Inc

31.4. Biogen Inc

31.5. Novavax Inc

31.6. Ichor Medical Systems

31.7. Emergent BioSolutions Inc.

31.8. Alnylam Pharmaceuticals Inc.

31.9. Dynavax Technologies

31.10. Bavarian Nordic

31.11. Siga Technologies Inc.

31.12. Elusys Therapeutics Inc.

31.13. Ology Bioservices

31.14. Altimmune Inc.

31.15. Hytest Limited

32. Global Biodefense Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biodefense Market

34. Recent Developments In The Biodefense Market

35. Biodefense Market High Potential Countries, Segments and Strategies

35.1 Biodefense Market In 2029 - Countries Offering Most New Opportunities

35.2 Biodefense Market In 2029 - Segments Offering Most New Opportunities

35.3 Biodefense Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson & Johnson Financial Performance
  • Table 81: Merck & Co. Financial Performance
  • Table 82: Sanofi SA Financial Performance
  • Table 83: Bristol-Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson & Johnson Financial Performance
  • Figure 81: Merck & Co. Financial Performance
  • Figure 82: Sanofi SA Financial Performance
  • Figure 83: Bristol-Myers Squibb Company Financial Performance

Frequently Asked Questions

Biodefense refers to the measures and strategies implemented to protect against biological threats, including the deliberate release of pathogens or biotoxins. This involves the development of detection systems, vaccines, treatments, and emergency response plans to mitigate the impact of biological attacks on public health and safety. Biodefense also includes research and policy efforts to prevent the misuse of biological agents. For further insights on this market, request a sample here

The market major growth driver - Impact Of Emerging Infectious Diseases Enhanced Biodefense Market. For further insights on this market, request a sample here

The biodefense market size has grown strongly in recent years. It will grow from $18.55 billion in 2024 to $20.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism. The biodefense market size is expected to see strong growth in the next few years. It will grow to " $28.1 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics. For further insights on this market, request a sample here

The biodefensemarket covered in this report is segmented –
1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications Subsegments:
1) By Anthrax: Bacillus Anthracis Vaccine; Anthrax Therapeutics
2) By Smallpox: Smallpox Vaccine; Antiviral Drugs For Smallpox
3) By Botulism: Botulism Antitoxin; Botulism Vaccine; Botulinum Neurotoxin Inhibitors
4) By Radiation Or Nuclear: Radiation Protection Drugs; Medical Countermeasures
5) By Other Types: Ricin; Plague; Tularemia; Viral Hemorrhagic Fevers; Other Biotoxins Or Biothreat Agents For further insights on this market,
request a sample here

North America was the largest region in the biodefense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals. For further insights on this market, request a sample here.

Major trends in this market include Rapid Advancements In Biodefense Technologies And Products. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon